Published in Bioorg Khim on April 01, 1995
Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj J (1998) 1.27
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med (2001) 1.53
Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity (2000) 1.47
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
[Molecular cloning, expression, and characterization of human mini-antibodies against enterotoxin C1 of Staphylococcus aureus]. Bioorg Khim (2009) 0.83
[Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms]. Bioorg Khim (2000) 0.80
Bispecific monoclonal antibodies to human interleukin 2 and horseradish peroxidase. Hybridoma (1993) 0.78
[Synthesis and immunochemical properties of peptides corresponding to sequences 59-72 and 25-36 of human interleukin-2]. Bioorg Khim (1989) 0.77
Muramyl peptide-binding sites are located inside target cells. FEBS Lett (1991) 0.77
[Immunogenic properties of the colloidal gold]. Izv Akad Nauk Ser Biol (2004) 0.76
[Conformation of fragment 66-72 of interleukin-2 complexed with a monoclonal antibody to interleukin-2]. Bioorg Khim (1993) 0.76
[Transcriptional regulation of TNF/LT locus in immune cells]. Mol Biol (Mosk) (2011) 0.75
[Preparation and characterization of monoclonal antibodies to the cholera toxin]. Bioorg Khim (2009) 0.75
[Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system]. Vopr Med Khim (1997) 0.75
[Bacteriorhodopsin retains the conformation of Val69-Gly72 fragment during functioning]. Bioorg Khim (2002) 0.75
[Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders]. Mol Gen Mikrobiol Virusol (2007) 0.75
[Serological study of a repertoire of human cancer antigens and autoantigens]. Mol Biol (Mosk) (2004) 0.75
[Cloning fragments of cDNA coding variable segments of light and heavy chains of monoclonal antibodies against human interleukin-2]. Bioorg Khim (1995) 0.75
[An analysis of the infectious morbidity in the troop personnel of a military district by using a personal computer]. Voen Med Zh (1993) 0.75
[The role of platelet activating factor in regulation of the phagocytic function of macrophages from different organs]. Biull Eksp Biol Med (1998) 0.75
[Synthesis and biological properties of polysaccharide-peptide conjugates as potential antigens for a vaccine against meningococci of serogroups A and B]. Bioorg Khim (2008) 0.75
[Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)]. Klin Med (Mosk) (1997) 0.75
[The production of mini antibodies against human granulocyte colony-stimulating factor using murine scFv combinatorial library]. Bioorg Khim (2002) 0.75
[Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)]. Kardiologiia (1973) 0.75
Production and characterization of monoclonal anti-idiotypic antibodies to muramylpeptide. FEBS Lett (1994) 0.75
[A new crystal form of the Fab fragment of a monoclonal antibody to human interleukin-2: the three-dimensional structure at 2.7 A resolution]. Bioorg Khim (2004) 0.75
[Antigenic structure of the Pro-rich region 536-566 of Bordetella pertussis pertactin (P.69). II. Analysis of peptide-specific antibodies]. Biokhimiia (1996) 0.75
[Preparation and characteristics of monoclonal antibodies to N-acetylglucosaminyl-(beta1-4)-N-acetylmuramoyl-alanyl-D-isoglutamine]. Bioorg Khim (1993) 0.75
[Differential effect of glucosaminylmuramyl dipeptide on the phenotype of melanoma sublines with different metastatic potential]. Mol Biol (Mosk) (1997) 0.75
[Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)]. Kardiologiia (1973) 0.75
[Endogenous Tumor necrosis factor alpha unmasks the binding sites for N-acetylglucosaminyl-(beta1-4)-N-acetylmuramyl-alanyl-D-isoglutamine on the surface of melanoma cells]. Bioorg Khim (2001) 0.75
[A method for the preparation of adjuvant peptide mimetics of GMDP with the use of monoclonal antibodies and combinatorial libraries of peptides in the format of phage display]. Bioorg Khim (2010) 0.75
[Cytokine receptors: functional asymmetry of subunits in the receptor complex]. Bioorg Khim (1997) 0.75
[Proteins and RNA in the neuron-neuroglia system of the nucleus raphe dorsalis of the suslik brain during hibernation]. Fiziol Zh SSSR Im I M Sechenova (1985) 0.75
[Induction of antimeningitis immunity by synthetic peptides. II. Immunoactive synthetic fragments of OpaB protein from Neisseria meningitidis]. Bioorg Khim (2001) 0.75
The occurrence of natural antibodies to minimal component of bacterial cell wall (N-acetylglucosaminyl-N-acetylmuramyl dipeptide) in sera from healthy humans. Immunol Lett (1996) 0.75
Generation of high-intensity spectral supercontinuum of more than two octaves in a water jet. Appl Opt (2016) 0.75
Biochemical characterization of glucosaminylmuramyldipeptide binding sites of murine macrophages. FEBS Lett (1994) 0.75
[Monoclonal antibodies to type A, B, E and F botulinum neurotoxins]. Bioorg Khim (2011) 0.75
[Study of the interaction of the monoclonal antibody to human interleukin-2 and its Fab-fragment with synthetic peptides --interleukin-2 fragments by (1)H-NMR]. Bioorg Khim (1991) 0.75
[The effect of platelet-activating factor and its synthetic analogs on Ia-antigen expression by mouse peritoneal macrophages]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75
[Production and characteristics of monoclonal antibodies to the diphtheria toxin]. Bioorg Khim (2009) 0.75
[Induction of anti-meningitis immunity using the synthetic peptides. I. The immunoreactive synthetic fragments of porin A from Neisseria meningitidis]. Bioorg Khim (2000) 0.75
[Isolation and characterization of the ALP1 protease from Aspergillus fumigatus and its protein inhibitor from Physarium polycephalum]. Bioorg Khim (2005) 0.75
[Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens]. Mol Gen Mikrobiol Virusol (2007) 0.75
[New acellular pertussis vaccine, containing glucosaminylmuramyldipeptide]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Synthesis of nitric oxide by mouse peritoneal macrophages induced by C-reactive protein]. Biull Eksp Biol Med (1998) 0.75
[Structure-functional study of glycosaminylmuramoyl peptides. The effect of chemical modification of N-acetylglucosaminyl-N-acetylmuramoyldipeptide on its immunomodulating properties in vivo and in vitro]. Bioorg Khim (1991) 0.75
[Localization of an antigenic determinant of recombinant interleukin-2, recognized by monoclonal antibody 13B1]. Bioorg Khim (1991) 0.75
[Antigenic structure of the Bordetella pertussis pertactin Pro-rich segment 536-566. I. Preparation and analysis of antisera to synthetic peptides]. Biokhimiia (1995) 0.75
[Induction of the anti-meningitis immunity with synthetic peptides. III. Immunoactive synthetic fragments of NspA protein from Neisseria meningitidis]. Bioorg Khim (2002) 0.75
[Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus]. Bioorg Khim (1990) 0.75
[Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. Biofizika (1997) 0.75